VICTORIA, BC, Sept. 19, 2024 /PRNewswire/ - Eupraxia Pharmaceuticals Inc. ("Eupraxia" or the "Company") (TSX: EPRX) (NASDAQ: EPRX), a clinical-stage biotechnology company leveraging its proprietary DiffuSphere™ technology to optimize drug delivery for applications with significant unmet...
Eupraxia Pharmaceuticals to Present at 20th ISDE World Congress for Esophageal Diseases
Seaking AlphaSeeking Alpha / Seaking Alpha 6 hours ago 1 Views
Comments